Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > UN CARBON COIN
View:
Post by biggdogg on Nov 14, 2022 3:22pm

UN CARBON COIN

Seriously Dumb Shareholders selling. 
Management are light years ahead of anyone in this industry, their carbon strategy is going to bring major value. Understand that a new carbon currency is coming, carbon credits are going to be very valuable. I would like to see their pricing strategy and how they will add credits to lower their cost per bottle. 

Comment by WarrantOfficer on Nov 15, 2022 8:20am
biggdogg: what is your analysis on finacing?
Comment by biggdogg on Nov 15, 2022 11:40am
Only TD selling down the stock. Many buyers at these levels. I think once the seller is done, there will be very little stock left at these prices. Once they can show this carbon credit plan, then I think they will get financed. What are they getting from RC? Is carbon credit an added revenue stream? Can it service a debt financing? many questions. How much power are they running, how many tonnes ...more  
Comment by postie1 on Nov 15, 2022 4:07pm
Personally, I think this is a buying opportunity. DYDD I wonder how much selling is being done because of margin calls due to the sell off in the markets over the last number of months or someone needing to raise money for other reasons(such as interest rates rising). There does not seem to be a run for the hills mentality driving this stock down but on a fairly small volume compared to the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1